Cutler Group’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$4K Buy
+4,500
New +$162K ﹤0.01% 1662
2022
Q3
Sell
-100
Closed -$5K 5532
2022
Q2
$5K Hold
100
﹤0.01% 3770
2022
Q1
$3K Buy
+100
New +$5.54K ﹤0.01% 4534
2021
Q4
Sell
-400
Closed -$1K 6099
2021
Q3
$1K Sell
400
-100
-20% -$11.4K ﹤0.01% 5454
2021
Q2
$3K Sell
500
-1,200
-71% -$140K ﹤0.01% 4847
2021
Q1
$13K Buy
1,700
+1,000
+143% +$152K ﹤0.01% 3590
2020
Q4
$5K Sell
700
-2,200
-76% -$244K ﹤0.01% 3702
2020
Q3
$6K Buy
2,900
+1,300
+81% +$80.9K ﹤0.01% 3402
2020
Q2
$2K Buy
1,600
+800
+100% +$28.7K ﹤0.01% 3849
2020
Q1
$4K Buy
+800
New +$21.5K ﹤0.01% 3235

Other funds holding TWST

Cutler Group's TWST Position: Q1 2024 in Review

Cutler Group opened a new position in Twist Bioscience (TWST) in Q1 2024: 1,700 shares worth $58K. The stake represents 0.02% of the portfolio and ranks #613 among its holdings. This is a return to the name: Cutler Group previously reported a position in TWST as recently as Q3 2023.

Cutler Group first reported a position in TWST in Q1 2021 and has held it in 8 quarters since. The position peaked at $101K in Q1 2021. 237 funds tracked by Wall St. Rank hold TWST as of Q1 2024.

  • Cutler Group held 1,700 shares of Twist Bioscience worth $58K as of Q1 2024.
  • Twist Bioscience was a new Cutler Group position in Q1 2024.
  • Twist Bioscience made up 0.02% of Cutler Group's portfolio in Q1 2024, its #613 holding.
  • Cutler Group first reported a position in Twist Bioscience in Q1 2021 and has held it in 8 quarters since.
  • Cutler Group's Twist Bioscience position peaked at $101K in Q1 2021.
  • 237 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.